Bêta-bloquants

Applications Centrally acting α-adrenoceptor agonist. Antihypertensive. References Urosevic, D., et al.: Br. J. Pharmacol., 142, 609 (2004), Remko, M., et al.: Bioorg. Med. Chem., 14, 1715 (2006), Nikolic, K., et al.: Bioorg. Med. Chem., 16, 7134 (2008).

rac-N-Desbutyroyl acebutolol is a prodrug that is metabolized to the active form, acebutolol. The metabolism of rac-N-desbutyroyl acebutolol is mediated through cytochrome P450 (CYP) enzymes, specifically CYP2D6. Rac-N-desbutyroyl acebutolol has been shown to inhibit the growth of bacteria in vitro and in vivo. It has also been shown to have therapeutic effects on diabetic patients with high levels of fatty acids in their blood. Rac-N-desbutyroyl acebutolol has also been found to be effective for the treatment of patients with polycarboxylic acid exposure and dna replication diseases.

Applications A dihydropyridine calcium channel blocker. Antihypertensive. References Safar, M., et al.: Clin. Pharmacol. Ther., 46, 94 (1989), Kharat, V.R., et al.: J. Pharm. Biomed. Anal., 28, 789 (2002), McCormack, A.J., et al.: Drugs, 63, 2327 (2003),

Applications Isotope labelled Coumatetralyl is used as an anticoagulant rodenticide. Coumatetralyl is widely used to control rodent populations. Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package References Jones, A., et al.: Bull Environ. Contain Toxicol., 56, 8 (1996), Brakes, C., et al.: J. Appl. Ecol., 42, 118 (2005), Giraudoux, P., et al.: Environ. Res., 102, 291 (2006),

Applications (±)-Carazolol-d7 is labelled (±)-Carazolol (C175810, HCl salt) which is a promising high-affinity beta-adrenergic receptor ligand for the noninvasive determination of beta receptor status using PET. References Berridge, M.S., et al.: J. Nucl. Med., 35(10), 1665 (1994)

Impurity Nifedipine EP Impurity A Applications The main Nifedipine metabolite in human plasma.This compound is a contaminant of emerging concern (CECs). References Guengerich, F., et al.: J. Biol. Chem., 261, 5051 (1986), Bork, R., et al.: J. Biol. Chem., 264, 910 (1989), Kerla, V., et al.: Biochem. Pharmacol., 44, 1745 (1992),

Applications Labelled Chlorthalidone. Chlorthalidone is used as a diuretic; antihypertensive. References Beisenherz, et al.: Arch. Int. Pharmacodyn. Ther., 161, 76 (1966); Zsoter, et al.: J. Pharmacol. Exp. Ther., 180, 723 (1972); Singer, J.M., et al.: Anal. Profiles Drug Subs., 14, 1 (1985);

Applications Antihypertensive. References Abrams, et al.: J. New Drugs, 4, 268 (1964), Medina, et al.: Biochem. Pharmacol., 18, 891 (1969), Goldenthal, E.I., Toxicol. Appl. Pharmacol., 18, 185 (1971),

Erythromycin E is a diluent that is used to make erythromycin solutions. It has been shown to have bioactive molecules by incubating it with chromatographic methods. These bioactive molecules are conjugates of erythromycin and methyl ethyl groups. Erythromycin E has also been shown to have genetic mechanisms, which may relate to its ability to inhibit the synthesis of inflammatory cytokines such as IL-1β and IL-8 in the airways. The acetate extraction method is used for the production of erythromycin E. This process involves extracting erythromycin from Streptomyces bacteria grown in an acetate buffer solution.

Stability Hygroscopic Applications Labelled Vatalanib. Vascular endothelial growth factor (VEGF) receptor tyrosine kinase inhibitor. Antineoplastic. References Wood, J.M., et al.: Cancer Res., 60, 2178 (2000), Morgan, B., et al.: J. Clin. Oncol., 21, 3955 (2003),

Impurity Rosuvastatin EP Impurity A Applications S-Desmethyl-S-(2-hydroxy-2-methylpropyl) Rosuvastatin Sodium Salt (Rosuvastatin EP Impurity A) is an impurity of Rosuvastatin (R700500).

Applications Pravastatin impurity. References Muramatsu, S., et al.: Biol. Pharm. Bull., 20, 1199 (1997), Serajuddin, A., et al.: J. Pharm. Sci., 88, 696 (1999),

Nadolol is a non-selective beta-adrenergic antagonist with antihypertensive and antiarrhythmic activities.

Applications Budralazine a new antihypertensive agent. Budralazine is a direct-acting vasodilator. References Moroi, R. et al.: Chem. Pharmac. Bull., 24, 2850 (1976); Ono, K. et al.: Xenobiotica, 9, 227 (1979); Yoshioka, M. et al.: Prog. Hypertens., 1992, 309 (1992);

Applications A compound present in olive oil. An important fine chemical intermediate with broad prospects for application development. References Shu, Y., et al.: Guangdong Huagong, 37, 108 (2010), Papadopoulos, G., et al.: J Am Oil Chem Soc, 68, 669 (1991),